Kleresca® SKR Treatment Graphic

Kleresca SKR®

Kleresca SKR® (Kleresca® Skin Rejuvenation) | The Kleresca® way: Effect without compromise.

Inspired by Photosynthesis

The innovation of the Kleresca® Skin Rejuvenation technology lies in its ability to create fluorescent light energy that activates your skin’s collagen-producing cells.

Works at Cellular level

The fluorescent light energy penetrates the skin and reaches into multiple layers, boosting collagen production by stimulating the natural processes of the skin.

Approximate 400% collagen increase

Studies show Kleresca® Skin Rejuvenation induces an approximate 400% increase in collagen production*.

The Kleresca® Skin Rejuvenation Treatment

Kleresca patient under treatment lamp during treatment
Kleresca patient under treatment lamp during treatment

Kleresca® Skin Rejuvenation is a non-invasive biophotonic treatment designed to rejuvenate your skin with high safety and efficacy and with little to no downtime.

This exciting new technology, designed in Denmark, has been used in Europe since 2014.

The Skin Clinic Fremantle is proud to have been the first clinic in WA to be able to offer this medical grade treatment that is:

  • Pain-free
  • Non-invasive
  • Needle-free
  • Long-lasting
Book Your Appointment
or contact us to arrange your appointment.

FAQ’s about Kleresca SKR®

Many different treatment modalities exist to counteract the effects of cutaneous ageing. Ablative lasers have traditionally been the mainstay for non-surgical facial rejuvenation. In recent years, non-ablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage1. Photo-rejuvenation is a novel non-ablative technique that induces skin rejuvenation through a type of low energy light therapy known as photobiomodulation.2,3

The process of photobiomodulation is based on evidence that photons are able to interact with the biological systems, cells and tissues, which consequently induce molecular pathways, modulating several aspects of cell biology2.

The clinical and biological effect of photobiomodulation is believed to originate from multiple cellular pathways, where individual wavelengths have been seen to trigger intra-cellular biochemical reactions. This often depends upon the state of the skin, where documented effects include:4

  • Anti-inflammatory response, especially beneficial for conditions such as acne, rosacea and keratosis pilaris.
  • Increased normalised cell growth for wound healing
  • Photorejuvenation
  • Scar prevention and recovery.

The Kleresca® Skin Rejuvenation treatment acts on the epidermis and the dermis of the skin. As the blue light with an optimised peak wavelength and fluency interacts with the Kleresca® photo converter gel, it is converted into a different set of fluorescent visible wavelengths in addition to the blue light emitted by the source. The photo converter gel creates hyper pulsed, multi-wavelength fluorescent light. this shift from shorter blue wavelengths to longer wavelengths within the blue, green, yellow, orange and red spectrum (400nm to 650nm) is caused by a phenomenon called Stoke’s shift. These wavelengths have the capacity to penetrate to various depths of the skin and to stimulate different tissues and cells within the skin5, Studies with the Kleresca biophotonic system in clinical trials have shown a significant reduction in inflammation in patients with moderate to severe acne6, longevity of results up to at least 6 months7, and increased collagen production with reduction in visible wrinkles8.

Kleresca® Skin Rejuvenation has a high safety profile and requires little to no downtime. Side effects – seen in some patients – are all non-permanent and may include redness, swelling and temporary hyperpigmentation (bronzing of an area of the skin). Side effects impact patients differently – if at all – so we always undertake a full consultation before beginning treatment.

The treatment improves your complexion by:

  • Inducing collagen production
  • Reducing pore size
  • Eliminating fine lines
  • Reducing signs of scars

Combined, these enhancements add up to an overall improvement in skin quality that patients typically describe as a feeling of radiance. Furthermore, Kleresca® Skin Rejuvenation has been shown to continue improving the skin quality even after the course of treatments has been completed.

Kleresca® Skin Rejuvenation was originally designed as a facial treatment but can also be used on the neck, décolletage and hands

During the treatment, a thin layer of the photoconverter gel is topically applied onto the targeted skin area and subsequently illuminated with the Kleresca® light. Together, the photoconverter gel and the light source provide a unique and dynamic photonic output, both in terms of wavelength and energy, delivered over 9 minutes. No UV or infrared light is emitted or generated. The gel can feel cold on the skin initially but is not painful, even during illumination. After the treatment, the exhausted photo converter gel is gently removed by cleansing. Moisturiser and SPF are then applied and you are able to use light mineral makeup immediately if you wish.

Kleresca® Skin Rejuvenation is a course of 4 treatments, delivered once a week for 4 consecutive weeks. Each treatment involves only a 30minute visit to the clinic, so can easily be performed in a lunch break.

This is a gentle, non-invasive treatment with no risk of bruising. Some patients experience a temporary slight bronzing to the skin of the treated areas immediately after the treatment, and there may also be some temporary redness or mild swelling.

Some patients have reported an immediate effect after one treatment. What’s more, improvements will continue even after the course of treatments has been completed.

You should experience long-lasting, noticeable improvements to your skin over the following months as multiple layers respond to the treatment. The skin repair process has been documented to continue even after the treatment has ended. Results will differ from patient to patient depending on skin quality and if the treatment is administered in combination with other techniques.

A full course of 4 face treatments costs $1,200.

You can pay for your treatment with cash, EFTPOS, Visa, Mastercard, American Express (merchant fees apply) or zipPay.


Before and after Kleresca® Skin Rejuvenation

Eliminating fine lines

Before treatment (left/top) and after 12 weeks (right/bottom).

Photo of eye area before Kleresca Skin Rejuvenatio
Photo of eye area 12 weeks after Kleresca Skin Rejuvenation

Reducing Pore Size

Before treatment (left/top) and after 12 weeks (right/bottom).

Photo of pores before Kleresca® Skin Rejuvenation
Photo of pores 12 weeks after Kleresca® Skin Rejuvenation

Inducing collagen production

Before treatment (left/top) and after 12 weeks (right/bottom).

Side profile photo before Kleresca SKR® treatment
Side profile photo after Kleresca SKR® treatment
Book Your Appointment
or contact us to arrange your appointment.

*With LED light as a control, the treatment delivers approximately a 400% increase in collagen production. These results were documented in-vitro and support findings from in vivo studies based on biopsies.

References

Sanclemente, G et al. A prospective split-face double blind randomised placebo controlled trial to assess the efficacy of methyl aminolevulinate + red light in patients with facial photodamage. J. Eur. Acad. Dermatology Venereol. 25, 49-58 (2011)
Freitas, L. F. de & Hamblin, M.R. Proposed mechanisms of photobiomodulation or low level light therapy. IEEE J See Top Quantum Electron 22 (2016)
Barolet, D et al. Regulation of skin collagen metabolism in vitro using a pulsed 660nm LED light source: clinical correlation wit a single blinded study. J. Invest. Dermatol. 129, 2751-9 (2009)</sub
Barolet, D. Light emitting diodes (LEDs) in dermatology. Semin. Cutan. Med. Surg. 27, 227-238 (2008)
Nielsen, M. E., Devemy, E., Jaworska, J. & Scapagnini, G. Introducing: photbiomodulation by low energy chromophore-induced fluorescent light. Mechanisms of Photobiomodulation Therapy. in IV, SPIE Photonics West BIOS, San Francisco 28Jan-2Feb (2017)
Antonious, C. et al. A multicentre, randomised, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int. J. Dermatol. 55, 1321-1328 (2016)
Nikolis, A. An extension of a multicentre, randomised, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int. J. Dermatol. (2017)
Nikolis, A. et al A randomised, placebo-controlled, single-blinded, split-face clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation in KLOX light-emitting diode light on facial rejuvenation. Chin. Cosmet. Invest. Dermatol. 9, 115-125 (2016)